TCB Team is a group of domain experts and writers focused on biotech, healthcare, and AI. They deliver original, high-signal coverage tailored for industry professionals, investors, and researchers. With a neutral and independent voice, the team transforms complex developments into clear, actionable insights.
110 articlesMostly Regulatory & Policy and Biopharmaceutical Industry
Medical TechnologyWith obesity continuing as a widespread health issue, telehealth companies are capitalizing on the convenience and accessibility of the newly approved oral Wegovy pill. The move reflects a growing trend of digital health platforms integrating pharmaceutical therapies for greater patient reach.
TCB TeamJan 6, 2026
Biotech InnovationArrowhead's gene-silencing drugs demonstrated efficacy in reducing fat accumulation in early obesity studies. This approach could complement existing therapies by tackling the biology of obesity through RNA interference technology.
TCB TeamJan 6, 2026